ask="16.25"
ask_size="7400"
average_daily_volume="155944"
bid="12.26"
bid_size="400"
book_value="6.55"
change="-0.87"
change_from_200_day_moving_average="0.78"
change_from_50_day_moving_average="-0.19"
change_from_52_week_high="-6.94"
change_From_52_week_low="4.24"
change_in_percent="-5.08%"
close="16.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="16.88"
high_52_weeks="23.20"
last_trade_date="1/17/2017"
last_trade_price="16.26"
last_trade_size="100"
last_trade_time="4:00pm"
low="16.21"
low_52_weeks="12.02"
market_capitalization="357.43M"
moving_average_200_day="15.48"
moving_average_50_day="16.45"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="32.71"
open="16.88"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+5.03%"
percent_change_from_50_day_moving_average="-1.13%"
percent_change_from_52_week_high="-29.91%"
percent_change_from_52_week_low="+35.27%"
previous_close="17.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.61"
price_per_sales="355.57"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="27.37"
stock_exchange="NGM"
symbol="ADMS"
volume="152045"
weeks_range_52="12.02 - 23.20"
